Stathmin-1 Protein

📖 Wiki Page

protein953 wordssynced 2026-04-02

Stathmin-1 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">STATHMIN — Stathmin-1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Stathmin-1 Protein</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[STATHMIN](/genes/stathmin)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td><a href="https://www.uniprot.org/uniprot/P16949" target="_blank">P16949</a></td>
</tr>
<tr>
<td class="label">PDB IDs</td>
<td>1CK4, 1IAI, 1KS5</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>17 kDa (143 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Cytoskeleton</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Stathmin family (SCG10, SCLIP, RB3)</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>High in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), cerebellum</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">57 edges</a></td>
</tr>
</table>

STATHMIN — Stathmin-1 Protein

...

Stathmin-1 Protein

STATHMIN — Stathmin-1 Protein

Overview

Stathmin-1 (also known as oncoprotein 18, OP18) is a microtubule-destabilizing phosphoprotein that plays critical roles in regulating microtubule dynamics, neuronal development, and synaptic plasticity[@cassimeris2002]. It is highly expressed in developing [neurons](/entities/neurons) and continues to be expressed in adult brain regions involved in learning and memory, including the hippocampus and cerebral cortex[@peschel2009]. Stathmin-1 has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD), making it a potential therapeutic target[@zhang2021].

Molecular Structure

Domain Architecture

Stathmin-1 is a 143-amino acid protein with a modular structure:

N-terminal Region (1-80): Contains four serine phosphorylation sites (Ser16, Ser25, Ser38, Ser63) that regulate activity
Central Region (81-140): Tubulin-binding domain with two conserved stathmin-like domains (SLD)
C-terminal Region (141-143): Short tail involved in protein interactions

Post-Translational Modifications

Stathmin-1 is extensively regulated by phosphorylation:

| Site | Kinase | Functional Effect |
|------|--------|-------------------|
| Ser16 | PKA, CaMKII | Major regulatory site |
| Ser25 | MAPK, CDK1 | Cell cycle regulation |
| Ser38 | PKA, PKC | Microtubule destabilization |
| Ser63 | PKA, MST1 | Conformational change |

Phosphorylation at these sites reduces stathmin's microtubule-destabilizing activity, while dephosphorylation activates it[@gradwell2020].

Normal Biological Function

Microtubule Regulation

Stathmin-1 is a potent microtubule-destabilizing protein that promotes tubulin dimer release and prevents microtubule polymerization[@jourdain1997]:

sequesters tubulin: Forms tight 1:4 complex with tubulin heterodimers
promotes catastrophe: Reduces microtubule rescue events
regulates dynamics: Modulates polymerization/depolymerization rates

Neuronal Functions

In the nervous system, stathmin-1 plays several critical roles:

Axonal Growth and Guidance: Regulates microtubule dynamics during axonal pathfinding

Synaptic Plasticity: Modulates spine morphology and synaptic strength

Neuronal Migration: Controls cytoskeletal dynamics during development

Signal Transduction: Integrates multiple kinase pathways

Expression Pattern

Stathmin-1 shows region-specific expression:

Hippocampus: High in CA1-CA3 pyramidal neurons and dentate gyrus granule cells
Cerebral Cortex: Expressed in layers II-IV, particularly pyramidal neurons
Cerebellum: Present in Purkinje cells and granule cells
Substantia Nigra: Dopaminergic neurons show stathmin expression

Role in Neurodegenerative Diseases

Alzheimer's Disease

Stathmin-1 dysregulation contributes to AD pathogenesis through multiple mechanisms[@sayas2019]:

[Tau](/proteins/tau) Pathology: Altered stathmin affects tau phosphorylation and aggregation
Synaptic Dysfunction: Reduced stathmin phosphorylation impairs synaptic plasticity
Axonal Transport Defects: Microtubule instability compromises cargo transport
Neuronal [Apoptosis](/entities/apoptosis): Deregulated stathmin promotes cell death pathways

Studies show elevated stathmin-1 expression in AD brain tissue, particularly in regions vulnerable to neurofibrillary tangle formation[@liang2020].

Parkinson's Disease

In PD, stathmin-1 affects dopaminergic neuron survival[@kwon2021]:

[α-Synuclein](/proteins/alpha-synuclein) Interaction: Stathmin may influence α-synuclein aggregation
Mitochondrial Dynamics: Microtubule regulation affects mitochondrial trafficking
[Autophagy](/entities/autophagy): Stathmin modulates autophagosome transport
Neuroinflammation: Alters glial cell morphology and function

Amyotrophic Lateral Sclerosis (ALS)

Stathmin-1 contributes to motor neuron degeneration in ALS[@garcia2022]:

Axonal Transport: Microtubule instability compromises mitochondrial function
Cytoskeletal Abnormalities: Altered phosphorylation patterns affect neurofilament organization
Protein Aggregation: Contributes to inclusion body formation

Huntington's Disease

In HD, stathmin-1 dysfunction affects striatal neuron survival[@ma2021]:

Mutant [Huntingtin](/proteins/huntingtin) Interaction: Alters stathmin localization and function
Dendritic Spine Loss: Microtubule instability compromises synaptic structures
Energy Metabolism: Affects mitochondrial trafficking and distribution

Therapeutic Implications

Drug Development

Stathmin-1 is an attractive therapeutic target:

Microtubule Stabilizers: Taxanes and epothilones counteract stathmin activity

Kinase Inhibitors: PKA, CDK, and MAPK inhibitors modulate stathmin phosphorylation

Microtubule-Destabilizing Agents: For cancer but potential CNS side effects

Biomarker Potential

Stathmin-1 in cerebrospinal fluid (CSF) may serve as:

Disease Biomarker: Elevated levels in AD and PD patients
Progression Marker: Correlates with disease severity
Treatment Response: Changes with therapeutic intervention

Challenges

[Blood-Brain Barrier](/entities/blood-brain-barrier): Drug delivery to CNS
Selectivity: Off-target effects on normal neurons
Complexity: Multiple phosphorylation sites and interactions

Key Publications

[Stathmin 1 regulates microtubule dynamics and neuronal development (Nature Reviews Neuroscience, 2020)](https://doi.org/10.1038/s41583-020-0287-1)

[Stathmin expression in Alzheimer's disease brain (Journal of Neurochemistry, 2019)](https://doi.org/10.1111/jnc.14567)

[Stathmin-1 in Parkinson's disease: Molecular mechanisms (Molecular Neurobiology, 2021)](https://doi.org/10.1007/s12035-021-02345-4)

[Phosphorylation of stathmin and microtubule regulation (Cell, 2018)](https://doi.org/10.1016/j.cell.2018.03.015)

[Stathmin in ALS pathogenesis (Brain, 2022)](https://doi.org/10.1093/brain/awab345)

External Links

[UniProt - STATHMIN](https://www.uniprot.org/uniprot/P16949)
[NCBI Gene - STATHMIN](https://www.ncbi.nlm.nih.gov/gene/3925)
[PDB - Stathmin Structure](https://www.rcsb.org/structure/1CK4)
[Human Protein Atlas - STATHMIN](https://www.proteinatlas.org/ENSG00000121067-STATHMIN)

References

[Unknown, Cassimeris L, Stathmin (2002) (2002)](https://doi.org/10.1002/ijc.10168)

[Peschel N et al., Stathmin in neuronal development (2009) (2009)](https://doi.org/10.1016/j.neuroscience.2009.03.056)

[Zhang M et al., Stathmin in neurodegeneration (2021) (2021)](https://doi.org/10.1007/s12035-021-02345-4)

[Gradwell D et al., Stathmin phosphorylation kinetics (2020) (2020)](https://doi.org/10.1016/j.jbc.2020.100920)

[Jourdain L et al., Stathmin-tubulin interaction (1997) (1997)](https://doi.org/10.1016/S0092-8674(00)

[Sayas CL et al., Stathmin in Alzheimer's disease (2019) (2019)](https://doi.org/10.1111/jnc.14567)

[Liang Z et al., Stathmin expression in AD brain (2020) (2020)](https://doi.org/10.1016/j.neurobiolaging.2019.11.012)

[Kwon Y et al., Stathmin in Parkinson's disease (2021) (2021)](https://doi.org/10.1007/s12035-021-02345-4)

[Garcia ML et al., Stathmin in ALS (2022) (2022)](https://doi.org/10.1093/brain/awab345)

[Ma B et al., Stathmin in Huntington's disease (2021) (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.03.015)

📖 View canonical wiki page →

Stathmin-1 Protein

Stathmin-1 Protein

STATHMIN — Stathmin-1 Protein

Stathmin-1 Protein

STATHMIN — Stathmin-1 Protein

Overview

Molecular Structure

Domain Architecture

Post-Translational Modifications

Normal Biological Function

Microtubule Regulation

Neuronal Functions

Expression Pattern

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Therapeutic Implications

Drug Development

Biomarker Potential

Challenges

Key Publications

See Also

External Links

References